Aurobindo Pharma shares drop following Jagan Reddy arrest

Posted By:
Subscribe to GoodReturns

Aurobindo Pharma shares drop following Jagan Reddy arrest
Aurobindo Pharma: Quotes, News
BSE 732.45BSE Quote7.5 (1.02%)
NSE 732.70NSE Quote8.5 (1.16%)
Shares of Aurobindo Pharma have dropped more than 3% today on the BSE, despite markets witnessing a buoyant trend.

Aurobindo Pharma is under Central Bureau of Investigation (CBI) scanner for alleged links with Y S Jagan Mohan Reddy, who was arrested late yesterday.

Shares of Aurobindo Pharma have been dropping over the last couple of months following ongoing reports of allegations with Jagan Reddy.

In early April the stock had plunged almost 8% in a single trading day as reports of the company receiving unfair advantages due to its links with Jagan Reddy surfaced.

Aurobindo Pharma is amongst the largest 'Vertically Integrated' pharmaceutical companies in India, Aurobindo has robust product portfolio spread over major product areas encompassing CVS, CNS, Anti-Retroviral, Antibiotics, Gastroenterologicals, Anti-Diabetics and Anti-Allergic with approved manufacturing facilities by USFDA, UKMHRA, WHO, MCC-SA, ANVISA-Brazil for both APIs & Formulations and has Global presence with own infrastructure, strategic alliances, subsidiaries & joint ventures.

GoodReturns.in

Read more about: bse, aurobindo pharma
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?